Rite Aid Execs Dodge Investor Suit Over Opioid Litigation
By Sydney Price · August 22, 2025, 8:14 PM EDT
Several of Rite Aid's executives have escaped a securities fraud suit accusing them of making misleading statements about the pharmacy retailer's opioid-related liabilities, with a Pennsylvania federal court finding they sufficiently...
To view the full article, register now.